What Enlarged Pores Actually Are
Pore size is primarily determined by genetics and sebum production. The pore is the opening of the follicle, and its visible size is affected by the volume of sebum passing through it, the elasticity of the surrounding skin, and the degree of oxidised sebum and dead skin cells sitting within it. This distinction matters for understanding what skincare can and cannot do.
Pores cannot be permanently opened or closed by temperature. They cannot be physically shrunk by topical products in a lasting way. What topical actives can do is reduce the factors that make pores appear larger: excess sebum, clogging, surrounding skin laxity, and uneven tone that draws the eye to the pore opening.
Vitamin B3 addresses several of these factors simultaneously, which is why the evidence for its use in improving pore appearance is stronger than for most other topical actives in this category. Used in an effective pore-clearing serum, it delivers measurable and visible improvement over consistent use.
What Vitamin B3 Does at the Cellular Level
Vitamin B3 is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in cellular energy production and DNA repair. At the skin level, it works through several independent mechanisms that are relevant to pore appearance and skin clarity.
First, it regulates sebum production. Studies have shown that topical vitamin B3 at concentrations of four percent and above reduces sebum excretion rates over six to twelve weeks. For people with congestion-prone or oily skin, this reduction in sebum at the source reduces the material that enlarges pores and creates the conditions for blockages.
Second, it reduces the transfer of melanin to skin cells. This mechanism is what makes vitamin B3 useful for hyperpigmentation and uneven tone. For pore clarity, it matters because post-inflammatory discolouration around the pore opening makes pores appear larger and more prominent than they would if the surrounding skin were even.
Third, it strengthens the skin barrier. A healthier barrier retains moisture more effectively, which supports the structural skin elasticity that keeps pores from appearing stretched or enlarged. Barrier-intact skin reflects light more evenly, which further reduces the visual prominence of pores.
The Concentration Question
The clinical evidence for vitamin B3 is concentration-dependent. At two percent, some cosmetic improvement in skin texture is observed. At four to five percent, the sebum-regulating and tone-evening effects become statistically significant. At ten percent, the full range of vitamin B3 benefits, including barrier reinforcement and anti-inflammatory activity, is well-supported by published data.
Most retail vitamin B3 products are formulated at two to four percent, partly for cost reasons and partly because high-dose free vitamin B3 causes flushing in some people. This flushing response, a temporary reddening and warming of the skin, is a vascular reaction to free nicotinamide and is more pronounced in reactive or sensitised skin types.
Encapsulated vitamin B3 at ten percent resolves this problem. The encapsulation shell controls the release rate, delivering the full therapeutic dose slowly across the skin contact period rather than in a single concentrated burst. The flushing response is eliminated because the skin is never exposed to a high concentration peak. The therapeutic dose is maintained because the total amount delivered over the contact period is the same. Encapsulated delivery at 10% therefore achieves what free vitamin B3 at 10% often cannot.
Vitamin B3 and Exfoliation: Complementary, Not Competing
The other major category of pore-targeting actives is exfoliating acids, primarily BHAs (beta-hydroxy acids) such as salicylic acid. BHAs are oil-soluble and penetrate into the follicle, clearing oxidised sebum and dead cell accumulation from inside the pore. This mechanism is different from vitamin B3 and complements rather than competes with it.
Encapsulated pore-clearing BHA at 15% delivers the exfoliant to follicle depth without the surface-drying effect that standard salicylic acid formulations often produce. When combined with encapsulated vitamin B3 at 10%, the two actives address pore appearance through two independent mechanisms simultaneously: BHA clears existing blockages and reduces the material that makes pores visible, while vitamin B3 reduces sebum at the source and evens the tone of surrounding skin.
The key to using these actives together effectively is delivery format. Free high-dose vitamin B3 and free high-dose BHA used in separate products can cause cumulative sensitisation. Encapsulated versions of both, in a single formula with supporting barrier ingredients, deliver clinical efficacy without the trade-off of barrier disruption.
What to Expect From Consistent Use
Vitamin B3 is not a quick-fix active. The sebum-regulating effect develops over six to twelve weeks of consistent use. Melanin transfer reduction similarly requires weeks of continuous contact to show visible results. This timeline is not a limitation but a reflection of how biological processes in the skin work. Sebaceous gland activity and melanocyte transfer are physiological processes, not surface conditions that change overnight.
People who start a vitamin B3 routine expecting visible pore reduction within two weeks will often stop before the active has had time to work. Those who continue through the initial six-week period consistently report improved skin clarity, reduced congestion, and more even tone in the pore area. By twelve weeks, the sebum-regulating effect is typically well established, and the pore-minimising benefits follow from the reduction in the factors that made pores prominent in the first place.
Twice-daily use of a well-formulated encapsulated vitamin B3 product maintains consistent skin contact across the full day and night cycle, compounding the effect faster than once-daily or alternate-day application.
Summary
Vitamin B3 is one of the most evidence-supported actives for pore clarity and skin congestion. At therapeutic concentrations of ten percent, delivered via encapsulation for tolerability and stability, it addresses sebum production, skin tone, and barrier health through independent mechanisms that reinforce each other. The results are not immediate but are well-documented and durable with consistent use.